Lastacaft Solution/ Drops
Product Images NDC 0023-4290

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lastacaft (NDC 0023-4290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lastacaft 01

Chemical structure of alcaftadine, the active ingredient in LASTACAFT ophthalmic solution 2.5 mg/mL, shown as a molecular diagram depicting its atomic bonds and ring structures.*

FDA Label Image

Lastacaft 03

Packaging label for LASTACAFT 0.25% (alcaftadine ophthalmic solution) 3 mL sterile drops. The label includes the product name, strength, ophthalmic use, inactive ingredients, storage instructions, and is marked as Rx only. It features the Allergan logo and barcodes, and specifies the NDC 0023-4290-03.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.